HomeInsightsStock Comparison

Aurobindo Pharma Ltd vs Mankind Pharma Ltd Stock Comparison

Aurobindo Pharma Ltd vs Mankind Pharma Ltd Stock Comparison

Last Updated on: Jun 02, 2025

Key Highlights

  • The Latest Trading Price of Aurobindo Pharma Ltd is ₹ 1138 as of 02 Jun 16:01.
  • The P/E Ratio of Aurobindo Pharma Ltd changed from 8.5 on March 2020 to 20.1 on March 2024 . This represents a CAGR of 18.78% over 5 yearsThe P/E Ratio of Mankind Pharma Ltd changed from 48.1 on March 2024 to 48.1 on March 2024 . This represents a CAGR of 0.00% over 1 years.
  • The Market Cap of Aurobindo Pharma Ltd changed from ₹ 24202 crore on March 2020 to ₹ 63835 crore on March 2024 . This represents a CAGR of 21.41% over 5 yearsThe Market Cap of Mankind Pharma Ltd changed from ₹ 92029 crore on March 2024 to ₹ 92029 crore on March 2024 . This represents a CAGR of 0.00% over 1 years.
  • The revenue of Aurobindo Pharma Ltd for the Mar '25 is ₹ 8516 crore as compare to the Dec '24 revenue of ₹ 8137 crore. This represent the growth of 4.66% The revenue of Mankind Pharma Ltd for the Mar '25 is ₹ 3333 crore as compare to the Dec '24 revenue of ₹ 3285 crore. This represent the growth of 1.43%.
  • The ebitda of Aurobindo Pharma Ltd for the Mar '25 is ₹ 1894 crore as compare to the Dec '24 ebitda of ₹ 1736 crore. This represent the growth of 9.08% The ebitda of Mankind Pharma Ltd for the Mar '25 is ₹ 932.5 crore as compare to the Dec '24 ebitda of ₹ 903.08 crore. This represent the growth of 3.26%.
  • The net profit of Aurobindo Pharma Ltd changed from ₹ 569.71 crore to ₹ 902.83 crore over 8 quarters. This represents a CAGR of 25.89% The net profit of Mankind Pharma Ltd changed from ₹ 494.19 crore to ₹ 424.65 crore over 8 quarters. This represents a CAGR of -7.30% .
  • The Dividend Payout of Aurobindo Pharma Ltd changed from 9.37 % on March 2020 to 13.49 % on March 2024 . This represents a CAGR of 7.56% over 5 yearsThe Dividend Payout of Mankind Pharma Ltd changed from 31.56 % on March 2020 to 0 % on March 2024 . This represents a CAGR of -100.00% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Aurobindo Pharma Ltd

  • Aurobindo Pharma Limited (APL), one of the world's top 5 manufacturers of semi synthetic penicillins was incorporated in 26th December 1986 as a private limited company.
  • Mr. P.V.Ramaprasad Reddy, Mr. K.Nityananda Reddy and a small, highly committed group of professionals founded it.
  • APL is developing, manufacturing and marketing active pharmaceutical ingredients (APIs also referred as bulk actives), intermediates and generic formulations.
  • The company's robust product portfolio is spread over 6 major product areas encompassing (Antibiotics, Anti-Retro Virals, CVS, CNS, Gastroenterologicals, and Anti-Allergics) with around 65 APIs in the non-antibiotics and over 55 APIs in the antibiotic segment and the World Health Organization (WHO), Geneva, has also approved Aurobindo's products.
  • APL is running with 24 manufacturing plants across the world conforming to GMP/ISO regulations and an extremely well equipped 9 R&D facilities.

About Mankind Pharma Ltd

  • Mankind Pharma Limited was incorporated on July 3, 1991, as a Private Limited Company with the name 'Mankind Pharma Private Limited', by the Registrar of Companies, Delhi and Haryana, at New Delhi.
  • Pursuant to conversion of Company to a Public Limited dated July 14, 2005, name of the Company was changed to 'Mankind Pharma Limited' and the RoC issued a fresh Certificate of Incorporation on April 13, 2006. The Company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations and chronic therapeutic areas across, as well as several consumer healthcare products.
  • It is present in several acute and chronic therapeutic areas in India, including anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins /minerals / nutrients and respiratory.

Aurobindo Pharma Ltd News Hub

News

Aurobindo Pharma arm incorporates WOS in Netherlands

The purpose of the incorporation of this wholly owned subsidiary is to expand the biopharm...

Read more

29 May 2025 08:40

News

Aurobindo Pharma announces board meeting date

Aurobindo Pharma will hold a meeting of the Board of Directors of the Company on 26 May 20...

Read more

17 May 2025 16:08

News

Aurobindo Pharma Ltd Slips 3.92%, BSE Healthcare index Shed 1.06%

Aurobindo Pharma Ltd fell 3.92% today to trade at Rs 1194. The BSE Healthcare index is dow...

Read more

06 May 2025 09:30

News

Aurobindo Pharma drops after fire incident at Kakinada facility

The incident, which occurred on 27 April 2025, has prompted a temporary suspension of oper...

Read more

29 Apr 2025 16:22

News

CuraTeQ Biologics s.r.o. receives positive opinion for biosimilar Dazublys' from EMA

CuraTeQ Biologics s.r.o., a wholly owned step-down subsidiary of Aurobindo Pharma, announc...

Read more

26 Apr 2025 13:58

News

Aurobindo Pharma rallies after arm receives USFDA nod for Dasatinib tablets

The drug is bioequivalent and therapeutically equivalent to the reference listed drug (RLD...

Read more

23 Apr 2025 12:05

Mankind Pharma Ltd News Hub

News

Mankind Pharma Ltd slips for fifth straight session

Mankind Pharma Ltd is down for a fifth straight session today. The stock is quoting at Rs ...

Read more

23 May 2025 13:35

News

Mankind Pharma slides after Q4 PAT drops 11% YoY to Rs 421 cr

However, revenue from operations increased 27.19% year-on-year (YoY) to Rs 3,079.37 crore ...

Read more

22 May 2025 15:37

News

Board of Mankind Pharma approves incorporation of WoS in Sri Lanka

The Board of Mankind Pharma at its meeting held on 21 May 2025 has approved the incorporat...

Read more

21 May 2025 18:52

News

Mankind Pharma allots 92,512 equity shares under ESOP

Mankind Pharma has allotted 92,512 equity shares under ESOP on 21 May 2025. Consequent to ...

Read more

21 May 2025 14:16

News

Mankind Pharma to discuss results

Mankind Pharma will hold a meeting of the Board of Directors of the Company on 21 May 2025...

Read more

09 May 2025 10:55

News

Mankind Pharma slides after Q3 PAT slips 16% YoY to Rs 380 cr

However, revenue from operations increased 23.9% year on year (YoY) to Rs 3,230 crore in t...

Read more

24 Jan 2025 12:12

SWOT Analysis Of Mankind Pharma Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Aurobindo Pharma Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Mankind Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Aurobindo Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Aurobindo Pharma Ltd and Mankind Pharma Ltd

Which company has a larger market capitalization, Aurobindo Pharma Ltd or Mankind Pharma Ltd?

Market cap of Aurobindo Pharma Ltd is 67,236 Cr while Market cap of Mankind Pharma Ltd is 102,057 Cr

What are the key factors driving the stock performance of Aurobindo Pharma Ltd and Mankind Pharma Ltd?

The stock performance of Aurobindo Pharma Ltd and Mankind Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aurobindo Pharma Ltd and Mankind Pharma Ltd?

As of June 2, 2025, the Aurobindo Pharma Ltd stock price is INR ₹1147.5. On the other hand, Mankind Pharma Ltd stock price is INR ₹2473.65.

How do dividend payouts of Aurobindo Pharma Ltd and Mankind Pharma Ltd compare?

To compare the dividend payouts of Aurobindo Pharma Ltd and Mankind Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions